Emapalumab Prevention of CAR-T Cell Associated Toxicities (clinicaltrials.gov) - Oct 7, 2026 - P2 | N=28 | Recruiting | Sponsor: Marcela V. Maus, M.D.,Ph.D. | Trial completion date: Aug 2027 ➔ Aug 2028 | Trial primary completion date: Aug 2026 ➔ Aug 2027
Trial completion date • Trial primary completion date • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • High-grade B-cell lymphoma • Large B Cell Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Primary Mediastinal Large B-Cell Lymphoma
|